Dual-Reporter FGF2 Secretion Assay for High-Throughput Screening
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for detecting FGF2 secretion and signaling are not suitable for high-throughput screening and do not accurately measure physiological responses to FGF2, limiting the identification of effective inhibitors for tumor therapy.
Innovation Solution
A method involving target cells that express a first fluorescent reporter in the nucleus, co-incubated with other cells or compounds, using a second fluorescent reporter to detect apoptotic cells, and calculating the quotient of fluorescence to identify FGF2 presence and modulation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If existing methods for detecting FGF2 secretion are used, then detection capability is provided, but high-throughput screening capability and measurement precision of physiological responses are insufficient
Solution Approach 1:
The assay segments the detection process into distinct fluorescent reporter channels: a first fluorescent reporter (e.g., GFP) for measuring living target cells and a second fluorescent reporter (e.g., RFP) for detecting apoptotic cells. This segmentation allows simultaneous high-throughput screening capability through automated fluorescence reading while maintaining measurement precision by specifically tracking physiological responses in each cell population separately.
Solution Approach 2:
Fluorescent reporters serve as intermediaries that translate biological states (cell viability, apoptosis) into quantifiable fluorescent signals. The first fluorescent reporter expresses in living target cells nuclei, while the second fluorescent reporter detects apoptotic cells, enabling precise measurement of physiological responses to FGF2 secretion and signaling in a high-throughput format.
2Measurement precision
If fluorescent reporters are used to detect target cells, then detection capability is improved, but the complexity of the assay system increases
Solution Approach 1:
The fluorescent reporter system performs multiple functions within a single assay: the first fluorescent reporter constitutively expressed in target cell nuclei serves as both a viability marker and a normalization reference, while the second fluorescent reporter activated in apoptotic cells provides death detection. This multi-functionality reduces overall system complexity by combining detection and normalization roles into integrated reporter constructs.
Solution Approach 2:
The assay utilizes different fluorescent colors (e.g., green fluorescent protein for living cells, red fluorescent protein for apoptotic cells) to distinguish cellular states. This color-based differentiation simplifies detection by allowing simultaneous monitoring of multiple parameters through standard fluorescence microscopy or flow cytometry without requiring complex additional reagents or procedures.
3Measurement precision
If quotient calculation of fluorescence is implemented, then identification precision of FGF2 presence is improved, but computational complexity increases
Solution Approach 1:
The quotient calculation of fluorescence intensities (second reporter fluorescence divided by first reporter fluorescence) provides feedback on FGF2 secretion and signaling status. This normalized ratio accounts for variations in cell number and fluorescence intensity, improving identification precision of FGF2 presence while maintaining computational simplicity through a straightforward division operation that can be easily implemented in high-throughput screening software.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables high-throughput screening for compounds that modulate FGF2 secretion and signaling, providing precise quantification and qualitative analysis of FGF2 effects on target cells, suitable for identifying potential tumor therapy targets.
Implementation Method 1
the target cells constitutively express a first reporter exciting fluorescence at a first wavelength
Implementation Method 2
detecting the presence of DNA from apoptotic cells with a second reporter exciting fluorescence at a wavelength that differs from the wavelength of the first reporter
Data Source
AI summary
A method for the identification of compounds modulating the biological activity of FGF2, the method comprising the use of target cells sensitive to the presence of FGF2 by obstructing proliferation, wherein the target cells constitutively express a first reporter in- the nucleus of living target cells.